MAIA Biotechnology Company Insiders

MAIA Biotechnology Management Team Effectiveness

The company has return on total asset (ROA) of (1.0711) % which means that it has lost $1.0711 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (5.5956) %, meaning that it created substantial loss on money invested by shareholders. MAIA Biotechnology's management efficiency ratios could be used to measure how well MAIA Biotechnology manages its routine affairs as well as how well it operates its assets and liabilities. As of November 22, 2024, Return On Tangible Assets is expected to decline to -2.74. The current year's Return On Capital Employed is expected to grow to -7.29. At present, MAIA Biotechnology's Net Tangible Assets are projected to increase significantly based on the last few years of reporting. The current year's Debt To Assets is expected to grow to 0.59, whereas Total Assets are forecasted to decline to about 7.3 M. As of November 22, 2024, Common Stock Shares Outstanding is expected to decline to about 12 M. In addition to that, Net Loss is expected to decline to about (11.8 M)

MAIA Biotechnology Workforce Comparison

MAIA Biotechnology Insider Trading History

MAIA Biotechnology Notable Stakeholders

The success or failure of an entity such as MAIA Biotechnology often depends on how effective the management is. MAIA Biotechnology management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of MAIA management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the MAIA management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.

Please note, the presentation of MAIA Biotechnology's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, MAIA Biotechnology's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of MAIA Biotechnology's management manipulating its earnings.

When running MAIA Biotechnology's price analysis, check to measure MAIA Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MAIA Biotechnology is operating at the current time. Most of MAIA Biotechnology's value examination focuses on studying past and present price action to predict the probability of MAIA Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MAIA Biotechnology's price. Additionally, you may evaluate how the addition of MAIA Biotechnology to your portfolios can decrease your overall portfolio volatility.